Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Michigan
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patients with MS either with relapsing or primary progressive course; who are newly starting on ocrelizumab (Ocrevus) at the time of enrollment
OR
Healthy controls who do not have a significant medical conditions such as cancer, chronic infection, or autoimmune disease, have not taken steroids in the past 2 months, and who are not on an immune suppressant medication.
Ability to give informed consent
Willing to have blood drawn as scheduled in the protocol
Willing and able to complete all procedures and evaluations related to the study
You may not be if
Medical or psychiatric conditions that may affect the patient's ability to give informed consent
Has received an experimental drug within 30 days of enrollment
